Topic: Antiretroviral Therapy

Antiretrovirals Raise Birth Defect Risk

Medical News Today - 13 days ago
Editor's Choice HIV-positive mothers can protected their babies from becoming infected with the virus if they take antiretroviral drugs during...

Foundation Releases Report On Achievements of Project Heart, a Groundbreaking Program to Expand HIV Prevention, Care, and Treatment in Sub-Saharan Africa

AllAfrica.com - 14 days ago
The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) today issued a report on the achievements of Project HEART, its groundbreaking initiative to...

MSF: 15,000 Congo AIDS victims likely will die

NBC 13 Albany (WNYT) - 15 days ago
Some 15,000 AIDS victims in Congo likely will die waiting for lifesaving drugs in the next three years, Doctors Without Borders warned Wednesday in ...

15,000 Congolese likely to die of AIDS

Queensland Courier-Mail, Australia - 15 days ago
DOCTORS Without Borders warns that 15,000 AIDS victims in Congo are likely to die in the next three years while waiting for lifesaving drugs. . ...

15,000 Congo AIDS victims likely to die

SkyNews, New Zealand - 15 days ago
Doctors Without Borders warns that 15,000 AIDS victims in the Congo are likely to die in the next three years while waiting for lifesaving drugs...

MSF warns 15,000 Congo AIDS victims to die in 3 years

CTV.ca - 15 days ago
View Larger Image. A A | Email | Print Tweet. Share . - Doctors Without Borders warns that 15,000 AIDS victims in Congo likely will die in the next...

Over 380,000 Malawians on free HIV drugs: officials

AFP Global Edition - 127 days ago
AIDS-ravaged Malawi has 383,000 people on free anti-retrovirals (ARVs), up from 5,000 when the programme started seven years ago, health authorities said Wednesday."I am pleased to report that 74,000 new patients were put on anti-retroviral therapy putting the ...

Blackwell on Health: A call to roll out HIV treatment aggressively

Posted - 209 days ago
There's much good news on the HIV front these days, underlined by a fascinating Ontario Superior Court judgment this week. As Adrian Humphreys...

Gilead Sciences Entered Into A License Agreement With Tibote

American Banking News - 226 days ago
Gilead Sciences (NASDAQ:GILD) announced that it has entered into a license agreement with Tibotec Pharmaceuticals for the development and...

US approves new HIV drug

AFP Global Edition - 265 days ago
The US Food and Drug Administration on Friday approved a new drug, Edurant, to fight HIV in combination with other antiretrovirals already on the market.Made by the New Jersey based Tibotec Therapeutics, Edurant helps block the virus from replicating and is ...